Solute-free water retention in preascitic cirrhotic rats following intravenous water loading

Journal of Physiology and Pharmacology

Volumn 60, Issue 4, 2009, Pages 111-117

  Sansoe, Giovanni ^a   Aragno, M ^b   Smedile, A ^b   Rizzetto, M ^b   Rosina, F ^a  

^a GRADENIGO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Ascites; Experimental liver cirrhosis; Sodium retention; Water metabolism

Indexed keywords

SODIUM CHLORIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; GLOMERULUS FILTRATION RATE; HENLE LOOP; KIDNEY PLASMA FLOW; LIVER CIRRHOSIS; MALE; NONHUMAN; PLASMA OSMOLARITY; RAT; WATER ABSORPTION; WATER LOADING; WATER METABOLISM; WATER RETENTION;

ALDOSTERONE; ANIMALS; ATRIAL NATRIURETIC FACTOR; EXTRACELLULAR FLUID; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY TUBULES, DISTAL; LIVER CIRRHOSIS; LOOP OF HENLE; MALE; OSMOLAR CONCENTRATION; POTASSIUM; RATS; RATS, WISTAR; RENIN; SODIUM; VASOPRESSINS; WATER; WATER-ELECTROLYTE IMBALANCE;

EID: 75749094797     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen J, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157.
2. Claria J, Jimenez W, Arroyo V, et al. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats. Gastroenterology 1989; 97: 1294-1299.
3. Wong F, Massie D, Hsu P, Dudley F. Renal response to a saline load in well-compensated alcoholic cirrhosis. Hepatology 1994; 20: 873-881.
4. Wood LJ, Massie D, McLean AJ, Dudley F. Renal sodium retention in cirrhosis: tubular site and relation to hepatic disfunction. Hepatology 1988; 8: 831-836.
5. Bernardi M, Di Marco C, Trevisani F, et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 1993; 105: 188-193
6. Wong F, Liu P, Tobe S, Morali G, Blendis L. Central blood volume in cirrhosis: measurement with radionuclide angiography. Hepatology 1994; 19: 312-321.
7. Lewis FW, Adair O, Rector WG Jr. Arterial vasodilatation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992; 102: 1024-1029.
8. Sansoe G, Ferrari A, Baraldi E, Castellana CN, De Santis MC, Manenti F. Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis. Gut 1999; 45: 750-755.
9. Levy M. Sodium retention and ascites formation in dogs with experimental portal hypertension. Am J Physiol 1977; 233: F572-F585.
10. Wong F, Liu P, Blendis L. The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis. Hepatology 2002; 35: 1449-1458.
11. Sansoe G, Biava AM, Silvano S, et al. Renal tubular events following passage from the supine to the standing position in patients with well compensated liver cirrhosis: loss of tubuloglomerular feedback. Gut 2002; 51: 736-741.
12. Anastasio P, Frangiosa A, Papalia T, et al. Renal tubular function by lithium clearance in liver cirrhosis. Semin Nephrol 2001; 21: 323-326.
13. Jonassen TEN, Marcussen N, Haugan K, et al. Functional and structural changes in the thick ascending limb of Henle's loop in rats with liver cirrhosis. Am J Physiol 1997; 273: R568-R577.
14. Jonassen TEN, Christensen S, Sorensen AM, et al. Effects of chronic octreotide treatment on renal changes during compensated liver cirrhosis in rats. Hepatology 1999; 29: 1387-1395.
15. Jonassen TEN, Christensen S, Kwon TH, Langhoff S, Salling N, Nielsen S. Renal water handling in rats with decompensated liver cirrhosis. Am J Physiol 2000; 279: F1101-F1109.
16. Wilkinson SP, Smith JK, Clarke M, et al. Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity and sodium and water retention. Clin Sci Mol Med 1977; 52: 469-475.
17. Wilkinson SP, Smith JK, Williams R. Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low renin" cirrhosis. Hypertension 1979; 1: 125-129.
18. Trevisani F, Bernardi M, Gasbarrini A, et al. Bed-restinduced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain "compensation"? J Hepatol 1992, 16: 190-196.
19. Jimenez W, Martinez-Pardo A, Arroyo V, et al. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 1985; 5: 245-250.
20. Jonassen TEN, Petersen JS, Sorensen AM, Andreasen F, Christensen S. Aldosterone receptor blockade inhibits increased furosemide-sensitive sodium reabsorption in rats with liver cirrhosis. J Pharmacol Exp Ther 1998; 287: 931-936.
21. Jonassen TEN, Nielsen S, Christensen S, Petersen JS. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis. Am J Physiol 1998; 275: F216-F225.
22. Fernandez-Llama P, Ageloff S, Fernandez-Varo G, et al. Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins. Kidney Int 2005; 67: 622-630.
23. Schuster VL, Seldin DW. Water clearance. In Clinical Disturbances of Water Metabolism, DW Seldin, G Giebisch (eds). Raven Press, New York, 1993.
24. Leng L, Szanyova M, Faix S, Cirio A. Renal response of sheep fed a low protein diet to intraportal infusion of arginine and glycine. Comp Biochem Physiol 1994; 108A: 343-347.
25. Tebot I, Faix S, Szanyova M, Cirio A, Leng L. Micropuncture study on urea movements in the kidney cortical tubules of low protein fed sheep. Vet Res 1998; 29: 99-105.
26. Suki W, Rector FC Jr, Seldin DW. The site of action of furosemide and other sulfonamide diuretics in the dog. J Clin Invest 1965; 44: 1458-1469.
27. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982; 83: 1183-1190.
28. Cole BR, Giangiacomo J, Ingelfinger JR. Robson AM. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate. N Engl J Med 1972; 287: 1109-1114.
29. Roe JH, Epstein JH, Goldstein NP. Aphotometric method for the determination of inulin in plasma and urine. J Biol Chem 1949; 178: 839-845.
30. Smith HW, Finkelstein N, Alminosa L. The renal clearance of substituted hippuric acid derivatives and other aromatic acids in dog and men. J Clin Invest 1945; 24: 388-403.
31. Sansoe G, Aragno M, Mastrocola R, et al. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis. Am J Physiol 2006; 290: F1337-F1343.
32. Clinical Physiology of Acid-Base and Electrolyte Disorders. Rose BD, Post, TW. (eds). McGraw-Hill, 2001, pp. 285-298.
33. Ethier JH, Kamel KS, Magner PO, Lemann JJr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis 1990; 15: 309-315.
34. The Kidney. Brenner BM, Rector WG. (eds). W.B. Saunders Company, 1996, pp. 999-1037.
35. Kamel KS, Quaggin S, Scheich A, Halperin ML. Disorders of potassium homeostasis: an approach based on pathophysiology. Am J Kidney Dis 1994; 24: 597-613.
36. Rose BD. New approach to disturbaces in the plasma sodium concentration. Am J Med 1986; 81: 1033-1040.
37. Gottschalk CW, Mylle M. Micropuncture study of the mammalian urinary concentrating mechanism: evidence for the countercurrent hypothesis. Am J Physiol 1959; 196: 927-936.
38. Jamison RL, Bennett CM, Berliner RW. Countercurrent multiplication by the thin loops of Henle. Am J Physiol 1967; 212: 357-366.
39. H2O formation in the rat. Kidney Int 1973; 3: 282-290.
40. Bartoli E, Satta A, Faedda R, Olmeo NA, Soggia G, Branca G. A furosemide test in the functional evaluation of the human nephron in vivo. J Clin Pharmacol 1983; 23: 56-64.
41. Wang Y, O'Connell JR, McArdle PF, et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106: 226-231.
42. +, 2Cl- cotransporter in HeLa cells. Proc Natl Acad Sci USA 2006; 103: 10883-10888.
43. Ramadori G, Moriconi F, Malik I, et al. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol 2008; 59(Suppl. 1): 107-117.
44. Yuan GJ, Zhou XR, Gong ZJ, et al. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World J Gastroenterol 2006; 12: 2375-2381.
45. Turban S, Wang XY, Knepper MA. Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO. Am J Physiol Renal Physiol 2003; 285: F843-F851.
46. Malinowska B, Lupinski S, Godlewski G, et al. Role of endocannabinoids in cardiovascular shock. J Physiol Pharmacol 2008; 59(Suppl. 8): 91-107.
47. Yang YY, Lee KC, Huang YT, et al. Inhibition of hepatic tumor necrosis factor-a attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers. Liver Int 2009; 29: 678-685.
48. Deutsch DG, Goligorsky MS, Schmid PC, et al. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 1997; 100: 1538-1546.
49. + by growth and by dietary salt restriction in rats. Am J Physiol 2007; 292: F1490-F1500.
50. Titze J. Water-free retention: interaction with hypertension and tissue hydration. Blood Purif 2008; 26: 95-99.